22 September 2025By Tom Collinstom@TheCork.ieAlexion, AstraZeneca Rare Disease has welcomed government officials, academic leaders, and industry partners to its hub in Cork, reinforcing the company’s commitment to productive partnerships and collaborative relationships within Ireland’s life sciences sector. Alongside established global operations in Dublin and Athlone, the Cork hub demonstrates Alexion’s dedication to building enduring connections across Ireland. The country continues to play a vital role as a global supply chain hub, delivering life-changing rare disease therapies worldwide—a complex mission that depends on strong collaboration to ensure quality, safety and timely access for patients in need. Cork serves as a base for senior technical roles in manufacturing, supply chain, quality, and technical operations, positioning Alexion and AstraZeneca as active contributors to a vibrant regional life sciences community. Across Dublin, Athlone, and Cork, Alexion and AstraZeneca employ approximately 1,400 people in development, manufacturing, supply, and commercial roles, working together with colleagues, partners, and educational experts to advance solutions for rare disease patients.